Those are the findings of a new study by researchers at Jacksonville University and the University of California, Davis. The study appears in the journal Child Development.

In the study, researchers looked at 90 mostly White children ages 5 to 10. The children listened to six illustrated stories in which two characters feel the same emotion after experiencing something positive (getting a new puppy), negative (spilling milk), or ambiguous (meeting a new teacher). Following each experience, one character has a separate optimistic thought, framing the event in a positive light, and the other has a separate pessimistic thought, putting the event in a negative light. Researchers described the subsequent thoughts verbally, then asked the children to judge each character's emotions and provide an explanation for those emotions. They were most interested in the degree to which children predicted different emotions for two characters in the same situation.

The researchers also had the children and their parents complete surveys to measure their individual levels of hope and optimism.

Children as young as 5 predicted that people would feel better after thinking positive thoughts than they would after thinking negative thoughts. They showed the strongest insight about the influence of positive versus negative thoughts on emotions in ambiguous situations. And there was significant development in the children's understanding about the emotion-feeling link as they grew older.

The study also found that children had the most difficulty understanding how positive thinking could boost someone's spirits in situations that involved negative events—such as falling down and getting hurt. In these coping situations, children's levels of hope and optimism played a role in their ability to understand the power of positive thinking, but parents' views on the topic played an even larger part.

"The strongest predictor of children's knowledge about the benefits of positive thinking—besides age—was not the child's own level of hope and optimism, but their parents'," reports Christi Bamford, assistant professor of psychology at Jacksonville University, who led the study when she was at the University of California, Davis.

The findings point to parents' role in helping children learn how to use positive thinking to feel better when things get tough, Bamford notes. "In short, parents should consider modeling how to look on the bright side."

Source: EurekAlert - via ZeitNews.org

Researchers from Northwestern University, Rush University Medical Center, Chicago, and the University of Duisburg-Essen Germany found that graphitic carbon is a key element in a lubricating layer that forms on metal-on-metal hip implants. The lubricant is more similar to the lubrication of a combustion engine than that of a natural joint.

The study was published on Dec. 23 2011 by the journal Science.

Prosthetic materials for hips, which include metals, polymers and ceramics, have a lifetime typically exceeding 10 years. However, beyond 10 years the failure rate generally increases, particularly in young, active individuals. Physicians would love to see that lifespan increased to 30 to 50 years. Ideally, artificial hips should last the patient's lifetime.

This is an X-ray of the hip region with a metal-on-metal implant superimposed and a schematic illustrating graphitic material on the surface of the implant. The red spheres represent the positions of the carbon atoms in a single layer of graphite. Credit: Northwestern University

"Metal-on-metal implants can vastly improve people's lives, but it's an imperfect technology," said Laurence D. Marks, a co-author on the paper who led the experimental effort at Northwestern. "Now that we are starting to understand how lubrication of these implants works in the body, we have a target for how to make the devices better."

Marks is a professor of materials science and engineering at Northwestern's McCormick School of Engineering and Applied Science.

The ability to extend the life of implants would have enormous benefits, in terms of both cost and quality of life. More than 450,000 Americans, most with severe arthritis, undergo hip replacement each year, and the numbers are growing. Many more thousands delay the life-changing surgery until they are older, because of the limitations of current implants.

"Hip replacement surgery is the greatest advancement in the treatment of end-stage arthritis in the last century," said co-author and principal investigator Dr. Joshua J. Jacobs, the William A. Hark, M.D./Susanne G. Swift Professor of Orthopedic Surgery and professor and chair of the department of orthopedic surgery at Rush. "By the time patients get to me, most of them are disabled. Life is unpleasant. They have trouble working, playing with their grandchildren or walking down the street. Our findings will help push the field forward by providing a target to improve the performance of hip replacements. That's very exciting to me."

Earlier research by team members Alfons Fischer at the University of Duisburg-Essen and Markus Wimmer at Rush University Medical Center discovered that a lubricating layer forms on metallic joints as a result of friction. Once formed, the layer reduces friction as well as wear and corrosion. This layer is called a tribological layer and is where the sliding takes place, much like how an ice skate slides not on the ice but on a thin layer of water.

But, until now, researchers did not know what the layer was. (It forms on the surfaces of both the ball and the socket.) It had been assumed that the layer was made of proteins or something similar in the body that got into the joint and adhered to the implant's surfaces.

The interdisciplinary team studied seven implants that were retrieved from patients for a variety of reasons. The researchers used a number of analytical tools, including electron and optical microscopies, to study the tribological layer that formed on the metal parts. (An electron microscope uses electrons instead of light to image materials.)

The electron-energy loss spectra, a method of examining how the atoms are bonded, showed a well-known fingerprint of graphitic carbon. This, together with other evidence, led the researchers to conclude that the layer actually consists primarily of graphitic carbon, a well-established solid lubricant, not the proteins of natural joints.

"This was quite a surprise," Marks said, "but the moment we realized what we had, all of a sudden many things started to make sense."

Metal-on-metal implants have advantages over other types of implants, Jacobs said. They are a lower wear alternative to metal-on-polymer devices, and they allow for larger femoral heads, which can reduce the risk of hip dislocation (one of the more common reasons for additional surgery). Metal-on-metal also is the only current option for a hip resurfacing procedure, a bone-conserving surgical alternative to total hip replacement.

"Knowing that the structure is graphitic carbon really opens up the possibility that we may be able to manipulate the system in a way to produce graphitic surfaces," Fischer said. "We now have a target for how we can improve the performance of these devices."

"Nowadays we can design new alloys to go in racing cars, so we should be able to design new materials for implants that go into human beings," Marks added.

The next phase, Jacobs said, is to examine the surfaces of retrieved devices and correlate the researchers' observations of the graphitic layer with the reason for removal and the overall performance of the metal surfaces. Marks also hopes to learn how graphitic debris from the implant might affect surrounding cells.

The science of tribology is the study of friction, lubrication and wear. The term comes from the Greek word "tribos," meaning rubbing or sliding.

More information: The Science paper is titled "Graphitic Tribological Layers in Metal-on-Metal Hip Replacements."

Source: Northwestern University - via ZeitNews.org

While fuel cells show a lot of promise for cleanly powering things such as electric cars, there's something keeping them from being more widely used than they currently are - they can be expensive. More specifically, the catalysts used to accelerate the chemical processes within them tend to be pricey. Work being done at Finland's Aalto University, however, should help bring down the cost of fuel cells. Using atomic layer deposition (ALD), researchers there are making cells that incorporate 60 percent less catalyst material than would normally be required.

In a fuel cell, the anode is coated with noble metal powder, which serves as a catalyst by reacting with the fuel. Using their ALD method, the scientists were able to use less powder to create a coating that was thinner and more even than conventional coatings, yet just as effective.

While fuel cells can be made with a number of different fuels (even including microbes or coal) and noble metals, the Aalto team is now developing low-cost cells that will run on methanol or ethanol, with a palladium catalyst. Probably the most well-known fuel cells are those that run on hydrogen, but such cells require a catalyst made of platinum, which is twice the price of palladium.

A paper on the research was recently published in the Journal of Physical Chemistry C.

Source: Gizmag - via ZeitNews.org

Many physicists around the world are hard at work trying to figure out new and exciting ways to create ultra-cold objects, the reason being is that if a system could be created that operates at or at least very near absolute zero, superconductors could be devised that might help create quantum computers, which would of course run at speeds that would make the current generation look quaint. Plus, theory suggests new states of matter might be discovered.

Now, new work by a group of physicists from Harvard appears to be coming closer than ever. They’ve figured out a way to remove entropy from a specialized system leaving much colder atoms behind. In their paper, published in Nature, they discuss how they’ve come up with something called an orbital excitation blockade, a form of interaction blockade, to reach temperatures tens to hundreds of times colder than current methods.

The team did their research in a three step process. In the first they shot atoms that make up rubidium with a laser, forcing them to glow in a way that made them give off more energy then they absorbed, making them cooler of course. By doing so they also created a system whereby they were able to control the atoms due to the pressure created by the laser. Thus they could hold them still, move them around, or even cause them to run into each other.

Next, the team caused the atoms to grow even colder by allowing evaporative cooling to due its work.

After that, the real work began. Here the team used meshes of lasers, called optical lattices to remove entropy from the system. The already cooled atoms were made to knock into one another using lasers ala the method used to start the whole process; this time in the optical lattices. In so doing, the excited activity of atom one dampened the excited activity of the other, a process the team calls an orbital excitation blockade. The team then removed the excited atoms from the system, leaving the unexcited, cold atoms behind, in effect, removing entropy from the system.

In actual experiments done thus, far, the team has demonstrated an ability to actually remove heat from a system using their excitation blockade, but only to a certain point. They believe more research will allow them to reach temperatures tens or even hundreds of a billionth of a degree above absolute zero, which would take them into truly unknown territory.

More information: Orbital excitation blockade and algorithmic cooling in quantum gases, Nature, 480, 500–503 (22 December 2011) doi:10.1038/nature10668

Abstract

Interaction blockade occurs when strong interactions in a confined, few-body system prevent a particle from occupying an otherwise accessible quantum state. Blockade phenomena reveal the underlying granular nature of quantum systems and allow for the detection and manipulation of the constituent particles, be they electrons, spins, atoms or photons. Applications include single-electron transistors based on electronic Coulomb blockade7 and quantum logic gates in Rydberg atoms. Here we report a form of interaction blockade that occurs when transferring ultracold atoms between orbitals in an optical lattice. We call this orbital excitation blockade (OEB). In this system, atoms at the same lattice site undergo coherent collisions described by a contact interaction whose strength depends strongly on the orbital wavefunctions of the atoms. We induce coherent orbital excitations by modulating the lattice depth, and observe staircase-like excitation behaviour as we cross the interaction-split resonances by tuning the modulation frequency. As an application of OEB, we demonstrate algorithmic cooling of quantum gases: a sequence of reversible OEB-based quantum operations isolates the entropy in one part of the system and then an irreversible step removes the entropy from the gas. This technique may make it possible to cool quantum gases to have the ultralow entropies required for quantum simulation of strongly correlated electron systems. In addition, the close analogy between OEB and dipole blockade in Rydberg atoms provides a plan for the implementation of two-quantum-bit gates in a quantum computing architecture with natural scalability.

A Harvard University press release can be found below:

Physicists at Harvard University have realized a new way to cool synthetic materials by employing a quantum algorithm to remove excess energy. The research, published this week in the journal Nature, is the first application of such an "algorithmic cooling" technique to ultra-cold atomic gases, opening new possibilities from materials science to quantum computation.

"Ultracold atoms are the coldest objects in the known universe," explains senior author Markus Greiner, associate professor of Physics at Harvard. "Their temperature is only a billionth of a degree above absolute zero temperature, but we will need to make them even colder if we are to harness their unique properties to learn about quantum mechanics."

Greiner and his colleagues study quantum many-body physics, the exotic and complex behaviors that result when simple quantum particles interact. It is these behaviors which give rise to high-temperature superconductivity and quantum magnetism, and that many physicists hope to employ in quantum computers.

"We simulate real-world materials by building synthetic counterparts composed of ultra-cold atoms trapped in laser lattices," says co-author Waseem Bakr, a graduate student in physics at Harvard. "This approach enables us to image and manipulate the individual particles in a way that has not been possible in real materials."

The catch is that observing the quantum mechanical effects that Greiner, Bakr and colleagues seek requires extreme temperatures.

"One typically thinks of the quantum world as being small," says Bakr, " but the truth is that many bizarre features of quantum mechanics, like entanglement, are equally dependent upon extreme cold."

The hotter an object is, the more its constituent particles move around, obscuring the quantum world much as a shaken camera blurs a photograph.

The push to ever-lower temperatures is driven by techniques like "laser cooling" and "evaporative cooling," which are approaching their limits at nanoKelvin temperatures. In a proof-of-principle experiment, the Harvard team has demonstrated that they can actively remove the fluctuations which constitute temperature, rather than merely waiting for hot particles to leave as in evaporative cooling.

Akin to preparing precisely one egg per dimple in a carton, this "orbital excitation blockade" process removes excess atoms from a crystal until there is precisely one atom per site.

"The collective behaviors of atoms at these temperatures remain an important open question, and the breathtaking control we now exert over individual atoms will be a powerful tool for answering it," said Greiner. "We are glimpsing a mysterious and wonderful world that has never been seen in this way before."

Source: PhysOrg - via ZeitNews.org

The microneedles painlessly pierce the top layer of skin, then gradually deliver the medication within them by harmlessly dissolving into the patient's bloodstream. As an added bonus, once everything is complete, there are no bio-hazardous used needles to dispose of. Now, bioengineers from Massachusetts' Tufts University have developed what they claim is an even better type of microneedle, which is made from silk.

With some types of existing microneedles, the harsh conditions required for their production can destroy the sensitive biochemicals that they were supposed to deliver. It can also be difficult to fine-tune the rate at which they deliver their medication, plus infections can sometimes occur where they enter the skin. According to the Tufts scientists, their silk microneedles address all of these problems.

The team started with aluminum molding masters that contained arrays of microneedles, each needle measuring 500 micrometers in height, with tips less than 10 micrometers in diameter. An elastomer was cast over those masters to create a negative mold, then a drug-laden silk protein was cast over that mold. Once the silk was dry, it was removed from the mold, then further processed using water vapor and various other means.

The whole procedure was conducted under ambient pressure and temperature, and resulted in biocompatible, dissolving silk microneedles impregnated with the large-molecule drug, horseradish peroxidase.

Using methods such as varying the silk protein's drying time, the researchers were able to alter its structure, which in turn allowed them to precisely control its rate of drug release. It was also found that adding tetracycline to the protein inhibited the growth of Staphylococcus aureus bacteria at the application site on the skin.

As with other types of microneedles, the silk needles can be shipped and stored without refrigeration.

Source: GIZMAG - via ZeitNews.org

Scientists are now trying to use plasmonic nanoparticles in cancer therapy whereby light energy is converted into heat in order to kill cancer cells. The advantage of such treatment is that it does not cause side effects that are common to chemotherapy. Mingyong Han at the A*STAR Institute of Materials Research and Engineering and co-workers have now developed gold plasmonic nanocrosses that are particularly suited to eliminating cancer cells in cancer therapy. The team demonstrated the usefulness of these nanocrosses by using them to kill human lung cancer cells.In general, metallic nanostructures have a particular frequency at which light excites electrons close to their surface. The collective movement of electrons, or resonance, in the metal is what converts the light energy into heat. The wavelength at which the resonance occurs is strongly dependent on the size and shape of the nanostructures.

For biomedical applications, the nanostructures should be effective no matter which direction they are illuminated from. Furthermore, the nanostructures should be efficient in absorbing near- to mid-infrared wavelengths because tissue is transparent to the light of these wavelengths.

Based on these requirements, the researchers decided to make gold nanocrosses (see image). In normal synthesis, however, gold would usually grow into the shape of the nanorods. To fabricate nanocrosses, the researchers added copper ions to the growth solution. The incorporation of small amounts of copper caused a twinning of the gold’s crystal structure, which in turn led to the growth of side arms from the crystal facets. “The unique cross-shaped gold structure enables multi-directional excitation to achieve a strong plasmonic resonance in the near- and mid-infrared region. This greatly lowers the laser power required for photothermal cancer therapy compared to nanorods,” says Han.

The researchers tested the performance of their gold nanocrosses by modifying their surfaces and binding them to human lung cancer cells. When irradiated with near-infrared laser light of relatively modest powers of 4.2 W/cm2 for 30 seconds, all cancer cells were killed. The researchers are now planning to test the effectiveness of the gold nanocrosses on animal models in future experiments.

Other applications of the gold nanocrosses are also possible, including photothermal imaging, in which small amounts of light are converted into local heat, or the sterilization of surfaces. “In our current research, we are studying gold nanocrosses for the photothermal destruction of superbugs on biofilms,” says Han.

Source: PhysOrg - via ZeitNews.org

While some ‘bugs’ are like migratory birds, making tiny magnets that they use to guide their navigation, this is the first bacterium to be found that makes two different kinds of magnetic particles.

The report, “A Cultured Greigite-Producing Magnetotactic Bacterium in a Novel Group of Sulfate-Reducing Bacteria,” describes the first successful attempt to grow the bacterium in the laboratory, opening the door to understanding how it works, and potentially harnessing its tools for manufacturing or environmental cleanup.

Led by University of Nevada Las Vegas microbiologist Dennis Bazylinski, the team includes Ames Laboratory scientist Tanya Prozorov, who performed characterization studies of the cultured bacterium. Bazylinski, formerly an Iowa State University researcher, and his postdoctoral associate, Christopher Lefèvre found the new bacterium, named BW-1, in a basin named Badwater on the edge of Death Valley National Park.

Magnetotactic bacteria, which may be among the oldest organisms on the planet, produce intracellular magnetic nanocrystals, which allow the swimming bacteria to orient along the geomagnetic lines of Earth. Magnetotactic bacteria serve as inspiration and a source of mineralization proteins for room temperature synthesis of magnetite nanocrystals with controlled sizes and morphologies. The isolation of this newly identified organism and the growth, essentially from a single cell, of the culture, will allow for systematic studies on the largely unknown greigite (Fe3S4) biomineralization in magnetotactic bacteria.

“Typically, bacteria produce either magnetite or greigite, but not both,” Prozorov said, “so these ‘bugs’ are something new. Over several years, our research group has studied many different bacteria using (electron) microscopy with subsequent measurements of their magnetic properties.”

“Clearly, determining the morphology and chemistry of intracellular magnetic nanoparticles is the key to understand their physical properties,” she adds. “ Despite the best effort to produce such nanoparticles in vitro, bacterial nanocrystals are still superior, exhibiting different morphologies including rod and tooth shapes.”

A detailed examination of its DNA revealed that BW-1 has two sets of magnetosome genes unlike other that produce only one mineral and have only one set of magnetosome genes. This suggests that the production of magnetite and greigite in BW-1 is likely controlled by separate sets of genes. This could be important in the mass production of either mineral for specific applications.

Due to a slight difference in physical and magnetic properties, greigite might prove superior to iron oxide in some applications. Greigite is also an important magnetic mineral in the sedimentary record, and is thought to play a significant role in the cycling of iron sulfur in modern, and perhaps ancient environments.

These results might provide the insight on the chemical conditions under which this greigite is formed, and will be of great interest to a broad scientific community, ranging from microbiologists to materials scientists and astrobiologists.

Source: Ames Laboratory - via ZeitNews.org

Highly excited Rydberg atoms can be 1,000 times larger than their ground state counterparts. Nearly ionized, they cling to faraway electrons almost beyond their reach. Trapping them efficiently is an important step in realizing their potential, the researchers say.

Giant Rydberg atoms become trapped in wells of laser light in a new highly efficient trap developed by University of Michigan physicists. They liken it to an egg carton. Image: Sarah Anderson

Here's how they did it:

"Our optical lattice is made from a pair of counter-propagating laser beams and forms a series of wells that can trap the atoms, similar to how an egg carton holds eggs," said Georg Raithel, a U-M physics professor and co-author of a paper on the work published in the current edition of Physical Review Letters. Other co-authors are physics doctoral student Sarah Anderson and recent doctoral graduate Kelly Younge.

In previous Rydberg atom traps, atoms came to rest at the top of the peaks of the laser light lattice, and tended to escape. University of Michigan researchers solved this problem by quickly flipping the lattice, trapping the giant Rydberg atoms in the wells, like eggs in a carton. Image: Sarah Anderson

The researchers developed a unique way to solve a problem that had been limiting trapping efficiency to single digit percentages. For Rydberg atoms to be trapped, they first have to be cooled to slow them down. The laser cooling process that accomplishes that tended to leave the atoms at the peaks of what the researchers call the "lattice hills." The atoms didn't often stay there.

"To overcome this obstacle, we implemented a method to rapidly invert the lattice after the Rydberg atoms are created at the tops of the hills," Anderson said. "We apply the lattice inversion before the atoms have time to move away, and they therefore quickly find themselves in the bottoms of the lattice wells, where they are trapped."

Raithel says there is plenty of technological room left to reach 100 percent trapping efficiency, which is necessary for advanced applications. Rydberg atoms are candidates to implement gates in future quantum computers that have the potential to solve problems too complicated for conventional computers. They could also be used in terahertz imaging and detection devices that could be used in airport scanners or surveillance equipment.

This work is supported by the National Science Foundation and the Department of Energy. The paper is titled "Trapping Rydberg atoms in an optical lattice."

Source: University of Michigan - via ZeitNews.org

While a simple tablet, taken by the patient with a sip of water, may be the easiest way to administer a drug, this may not always be the most suitable. Some drugs are subjected to degradation by the body, while others, such as cancer medications, can be more effective if they are delivered directly to the diseased tissue site. Such a delivery could improve the effectiveness of the treatment and potentially reduce side effects.

Yiyan Yang and Jeremy Tan from the A*STAR Institute of Bioengineering and Nanotechnology, working in collaboration with researchers from the IBM Almaden Research Center and Stanford University in the USA, have reported the preparation of biodegradable, water-soluble polymers that can be loaded with the cancer drug Paclitaxel and injected directly into tumor tissues. Warming to body temperature causes the release of the therapeutic cargo with the system showing improvement in killing cancer cells over treatment with the drug alone.

Rather than being made from repeating units of a single monomer, the polymers described are a type of block copolymer—a polymer with one block that contains hydrophilic and hydrophobic groups and another block that contains hydrophobic groups. It is through the careful balance between these groups that the temperature-responsive property of the polymer is achieved.

To make the copolymers, Yang and co-workers used the process of living polymerization, which allows the polymer chains to keep growing until the supply of monomer is exhausted. When more monomers are added, polymerization will restart. The approach allows polymers with different sized blocks of hydrophilic and hydrophobic groups to be built easily to optimize the properties. It also results in polymers with a narrow distribution of molecular weights—an important factor in producing polymers with consistent properties throughout a sample.

Thermoresponsive polymers have been studied before, with one of the most intensively investigated being poly(N-isopropylacrylamide) (PNIPAAm), which was first synthesized in the 1950s. The critical difference in the new polymers described by Yang and co-workers is that they are both non-toxic and biodegradable. “After these polymers performed their task of delivering their important cargos, they should break down and be excreted without significant additional side effects,” says Yang. “We are now planning to further work with the IBM Almaden Research Center and other industrial partners to evaluate the in vivo toxicity and efficacy of this system for the delivery of therapeutics.”

Source: Agency for Science, Technology and Research - via ZeitNews.org

A team of Weizmann Institute scientists has turned the tables on an autoimmune disease. In such diseases, including Crohn's and rheumatoid arthritis, the immune system mistakenly attacks the body's tissues. But the scientists managed to trick the immune systems of mice into targeting one of the body's players in autoimmune processes, an enzyme known as MMP9. The results of their research appear today in Nature Medicine.

Prof. Irit Sagi of the Biological Regulation Department and her research group have spent years looking for ways to home in on and block members of the matrix metalloproteinase (MMP) enzyme family. These proteins cut through such support materials in our bodies as collagen, which makes them crucial for cellular mobilization, proliferation and wound healing, among other things. But when some members of the family, especially MMP9, get out of control, they can aid and abet autoimmune disease and cancer metastasis. Blocking these proteins might lead to effective treatments for a number of diseases.

Originally, Sagi and others had designed synthetic drug molecules to directly target MMPs. But these drugs proved to be fairly crude tools that had extremely severe side effects. The body normally produces its own MMP inhibitors, known as TIMPs, as part of the tight regulation program that keeps these enzymes in line. As opposed to the synthetic drugs, these work in a highly selective manner. An arm on each TIMP is precisely constructed to reach into a cleft in the enzyme that shelters the active bit – a metal zinc ion surrounded by three histidine peptides – closing it off like a snug cork. 'Unfortunately,' says Sagi, 'it is quite difficult to reproduce this precision synthetically.'

Dr. Netta Sela-Passwell began working on an alternative approach as an M.Sc. student in Sagi's lab, and continued on through her Ph.D. research. She and Sagi decided that, rather than attempting to design a synthetic molecule to directly attack MMPs, they would try trick the immune system to create natural antibodies that target MMP-9 through immunization. Just as immunization with a killed virus induces the immune system to create antibodies that then attack live viruses, an MMP immunization would trick the body into creating antibodies that block the enzyme at its active site.

Together with Prof. Abraham Shanzer of the Organic Chemistry Department, they created an artificial version of the metal zinc-histidine complex at the heart of the MMP9 active site. They then injected these small, synthetic molecules into mice and afterward checked the mice's blood for signs of immune activity against the MMPs. The antibodies they found, which they dubbed 'metallobodies,' were similar but not identical to TIMPS, and a detailed analysis of their atomic structure suggested they work in a similar way – reaching into the enzyme's cleft and blocking the active site. The metallobodies were selective for just two members of the MMP family – MMP2 and 9 – and they bound tightly to both the mouse versions of these enzymes and the human ones.

As they hoped, when they had induced an inflammatory condition that mimics Crohn's disease in mice, the symptoms were prevented when mice were treated with metallobodies. 'We are excited not only by the potential of this method to treat Crohn's,' says Sagi, but by the potential of using this approach to explore novel treatments for many other diseases.' Yeda, the technology transfer arm of the Weizmann Institute has applied for a patent for the synthetic immunization molecules as well as the generated metallobodies.

Source: Weizmann Institute of Science - via ZeitNews.org